Add like
Add dislike
Add to saved papers

A Case of EBV-Associated Blastic Lymphoplasmacytic Proliferation in an Esophageal Ulcer with a Self-Limiting Course: Overlapping Lesion between EBV Mucocutaneous Ulcer and Polymorphic Lymphoplasmacytic Disorder.

Histopathology 2019 Februrary 7
B cell lymphoproliferative disorders (LPD) of varied malignant potential occur in association with immunodeficiency and include among others, follicular hyperplasia, infectious mononucleosis-like hyperplasia, plasmacytic hyperplasia, polymorphic B-lymphoproliferative disorders and the recently described clinicopathologic entity named as EBV-positive mucocutaneous ulcer (EBV-MCU). EBV-MCU is a localized and usually self-limited EBV-associated LPD characterized by a circumscribed ulcer involving oropharyngeal mucosa, skin, or gastrointestinal tract reported most often in elderly patients with presumed age-associated immunodeficiency. Histologically, EBV-MCU is characterized by a polymorphous infiltrate, which frequently includes atypical large B cells with Hodgkin/Reed-Sternberg (HRS) like cells admixed with abundant reactive T cells usually forming a rim around the base of the lesion. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app